Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives

John R. Srigley, Mahul Amin, Liliane Boccon-Gibod, Lars Egevad, Jonathan Ira Epstein, Peter A. Humphrey, Gregor Mikuz, Don Newling, Sten Nilsson, Wael Sakr, Thomas M. Wheeler, Rodolfo Montironi

Research output: Contribution to journalArticle

Abstract

An understanding of prognosis in cancer medicine is important for patient care, research and cancer control programs. In prostate cancer, prognostic (predictive) factors are particularly important given the marked heterogeneity of this disease at clinical, morphologic and biomolecular levels. Clinical stage and histologic grade have historically played major roles in defining heterogeneity in prostate cancer. More recently, serum prostate-specific antigen measurement has assumed a significant prognostic role. Over the last two decades there has been an explosion of research into biomarkers, many of which have been purported to have prognostic significance. In this paper we present an overview of the various consensus initiatives that have transpired over the last dozen years. Criteria for evaluating prognostic factors and classifications of predictive factors have emerged that have proven useful and advanced our understanding of the biology of prostate cancer. The results of these consensus initiatives form a foundation on which the current international consultation on prognosis (prediction) in prostate cancer is built. Advances in our understanding of the new and promising prognostic factors will require a more rigorous evidence-based approach to the analysis of published studies. Furthermore, appropriate mathematical models for the analysis of the multiple factors that influence a prognostic system will have to be employed.

Original languageEnglish (US)
Pages (from-to)8-19
Number of pages12
JournalScandinavian Journal of Urology and Nephrology, Supplement
Volume39
Issue number216
DOIs
StatePublished - May 2005

Fingerprint

Internationality
Prostatic Neoplasms
Explosions
Prostate-Specific Antigen
Research
Statistical Factor Analysis
Neoplasms
Patient Care
Theoretical Models
Referral and Consultation
Biomarkers
Medicine
Serum

Keywords

  • Historical aspects
  • Prediction
  • Previous consensus initiatives
  • Prognostic factors
  • Prostate cancer

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Prognostic and predictive factors in prostate cancer : Historical perspectives and recent international consensus initiatives. / Srigley, John R.; Amin, Mahul; Boccon-Gibod, Liliane; Egevad, Lars; Epstein, Jonathan Ira; Humphrey, Peter A.; Mikuz, Gregor; Newling, Don; Nilsson, Sten; Sakr, Wael; Wheeler, Thomas M.; Montironi, Rodolfo.

In: Scandinavian Journal of Urology and Nephrology, Supplement, Vol. 39, No. 216, 05.2005, p. 8-19.

Research output: Contribution to journalArticle

Srigley, JR, Amin, M, Boccon-Gibod, L, Egevad, L, Epstein, JI, Humphrey, PA, Mikuz, G, Newling, D, Nilsson, S, Sakr, W, Wheeler, TM & Montironi, R 2005, 'Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives', Scandinavian Journal of Urology and Nephrology, Supplement, vol. 39, no. 216, pp. 8-19. https://doi.org/10.1080/03008880510030914
Srigley, John R. ; Amin, Mahul ; Boccon-Gibod, Liliane ; Egevad, Lars ; Epstein, Jonathan Ira ; Humphrey, Peter A. ; Mikuz, Gregor ; Newling, Don ; Nilsson, Sten ; Sakr, Wael ; Wheeler, Thomas M. ; Montironi, Rodolfo. / Prognostic and predictive factors in prostate cancer : Historical perspectives and recent international consensus initiatives. In: Scandinavian Journal of Urology and Nephrology, Supplement. 2005 ; Vol. 39, No. 216. pp. 8-19.
@article{7afc2bf453bf495aa70f94b94957c83a,
title = "Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives",
abstract = "An understanding of prognosis in cancer medicine is important for patient care, research and cancer control programs. In prostate cancer, prognostic (predictive) factors are particularly important given the marked heterogeneity of this disease at clinical, morphologic and biomolecular levels. Clinical stage and histologic grade have historically played major roles in defining heterogeneity in prostate cancer. More recently, serum prostate-specific antigen measurement has assumed a significant prognostic role. Over the last two decades there has been an explosion of research into biomarkers, many of which have been purported to have prognostic significance. In this paper we present an overview of the various consensus initiatives that have transpired over the last dozen years. Criteria for evaluating prognostic factors and classifications of predictive factors have emerged that have proven useful and advanced our understanding of the biology of prostate cancer. The results of these consensus initiatives form a foundation on which the current international consultation on prognosis (prediction) in prostate cancer is built. Advances in our understanding of the new and promising prognostic factors will require a more rigorous evidence-based approach to the analysis of published studies. Furthermore, appropriate mathematical models for the analysis of the multiple factors that influence a prognostic system will have to be employed.",
keywords = "Historical aspects, Prediction, Previous consensus initiatives, Prognostic factors, Prostate cancer",
author = "Srigley, {John R.} and Mahul Amin and Liliane Boccon-Gibod and Lars Egevad and Epstein, {Jonathan Ira} and Humphrey, {Peter A.} and Gregor Mikuz and Don Newling and Sten Nilsson and Wael Sakr and Wheeler, {Thomas M.} and Rodolfo Montironi",
year = "2005",
month = "5",
doi = "10.1080/03008880510030914",
language = "English (US)",
volume = "39",
pages = "8--19",
journal = "Scandinavian Journal of Urology and Nephrology, Supplement",
issn = "0300-8886",
publisher = "Taylor and Francis Ltd.",
number = "216",

}

TY - JOUR

T1 - Prognostic and predictive factors in prostate cancer

T2 - Historical perspectives and recent international consensus initiatives

AU - Srigley, John R.

AU - Amin, Mahul

AU - Boccon-Gibod, Liliane

AU - Egevad, Lars

AU - Epstein, Jonathan Ira

AU - Humphrey, Peter A.

AU - Mikuz, Gregor

AU - Newling, Don

AU - Nilsson, Sten

AU - Sakr, Wael

AU - Wheeler, Thomas M.

AU - Montironi, Rodolfo

PY - 2005/5

Y1 - 2005/5

N2 - An understanding of prognosis in cancer medicine is important for patient care, research and cancer control programs. In prostate cancer, prognostic (predictive) factors are particularly important given the marked heterogeneity of this disease at clinical, morphologic and biomolecular levels. Clinical stage and histologic grade have historically played major roles in defining heterogeneity in prostate cancer. More recently, serum prostate-specific antigen measurement has assumed a significant prognostic role. Over the last two decades there has been an explosion of research into biomarkers, many of which have been purported to have prognostic significance. In this paper we present an overview of the various consensus initiatives that have transpired over the last dozen years. Criteria for evaluating prognostic factors and classifications of predictive factors have emerged that have proven useful and advanced our understanding of the biology of prostate cancer. The results of these consensus initiatives form a foundation on which the current international consultation on prognosis (prediction) in prostate cancer is built. Advances in our understanding of the new and promising prognostic factors will require a more rigorous evidence-based approach to the analysis of published studies. Furthermore, appropriate mathematical models for the analysis of the multiple factors that influence a prognostic system will have to be employed.

AB - An understanding of prognosis in cancer medicine is important for patient care, research and cancer control programs. In prostate cancer, prognostic (predictive) factors are particularly important given the marked heterogeneity of this disease at clinical, morphologic and biomolecular levels. Clinical stage and histologic grade have historically played major roles in defining heterogeneity in prostate cancer. More recently, serum prostate-specific antigen measurement has assumed a significant prognostic role. Over the last two decades there has been an explosion of research into biomarkers, many of which have been purported to have prognostic significance. In this paper we present an overview of the various consensus initiatives that have transpired over the last dozen years. Criteria for evaluating prognostic factors and classifications of predictive factors have emerged that have proven useful and advanced our understanding of the biology of prostate cancer. The results of these consensus initiatives form a foundation on which the current international consultation on prognosis (prediction) in prostate cancer is built. Advances in our understanding of the new and promising prognostic factors will require a more rigorous evidence-based approach to the analysis of published studies. Furthermore, appropriate mathematical models for the analysis of the multiple factors that influence a prognostic system will have to be employed.

KW - Historical aspects

KW - Prediction

KW - Previous consensus initiatives

KW - Prognostic factors

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=22144463914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144463914&partnerID=8YFLogxK

U2 - 10.1080/03008880510030914

DO - 10.1080/03008880510030914

M3 - Article

C2 - 16019756

AN - SCOPUS:22144463914

VL - 39

SP - 8

EP - 19

JO - Scandinavian Journal of Urology and Nephrology, Supplement

JF - Scandinavian Journal of Urology and Nephrology, Supplement

SN - 0300-8886

IS - 216

ER -